Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China
Tóm tắt
Tuberculosis (TB) remains a significant global public health problem. China has the second highest TB burden in the world. With a growing TB population with diabetes mellitus (DM), the TB control system faces mounting challenges. To date, evidence remains inconclusive regarding the association between TB-DM co-morbidity and delayed diagnosis of TB patients. This study aims to assess the diagnostic delay of TB patients with known DM and identify the factors associated with this delay. Data was collected from China’s Tuberculosis information management system in two counties of Zhejiang province, China. Patient delay, health system delay and total diagnostic delay are defined as follows: 1) the interval between the onset of TB symptoms and first visit to any health facility; 2) from the first visit to the health facility to the confirmed TB diagnosis in the designated hospital; 3) the sum of patient and health system’s respective delays. Comparison of these delays was made between TB patients with and without DM using Mann-Whitney U test and Chi-square test. Univariate and multivariate regression analysis was used to identify factors influencing delays among TB patients with DM. Of 969 TB patients, 67 (7%) TB patients had DM co-morbidity. Compared with TB patients without DM, TB patients with DM experienced significantly shorter health system delays (p < 0.05), and there was a significantly lower proportion of patients whose health system delayed> 14 days (7.0% vs. 18%, p < 0.05). However, no significant difference was observed between both patient categories regarding patient delay and total diagnostic delay. The multivariate regression analysis suggested that TB patients with DM who were aged < 60 years (AOR = 3.424, 95%CI: 1.008–11.627, p < 0.05) and non-severe cases (AOR = 9.725, 95%CI: 2.582–36.626, p < 0.05) were more likely to have a total diagnostic delay of> 14 days. Our study suggests that DM does not contribute to further diagnostic delay as expected. Instead, we observed significantly improved health system delay among TB patients with DM. The findings indicate the importance of early screening and diagnosis for TB among diabetic patients and of strengthening the integrated control and management of TB and diabetic programs.
Tài liệu tham khảo
World Health Organization. Global tuberculosis report 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1. Accessed 17 May 2020.
Sreeramareddy CT, Qin ZZ, Satyanarayana S, Subbaraman R, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18(3):255–66.
Wang Q, Ma A, Han X, Zhao S, Cai J, Kok FJ, et al. Hyperglycemia is associated with increased risk of patient delay in pulmonary tuberculosis in rural areas. J Diabetes. 2017;9(7):648–55.
Lin Y, Enarson DA, Chiang CY, Rusen ID, Qiu LX, Kan XH, et al. Patient delay in the diagnosis and treatment of tuberculosis in China: findings of case detection projects. Public Health Action. 2015;5(1):65–9.
Cai J, Wang X, Ma A, Wang Q, Han X, Li Y. Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis. PLoS One. 2015;10(3):e0120088.
Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8:15.
Chen HG, Liu M, Jiang SW, Gu FH, Huang SP, Gao TJ, et al. Impact of diabetes on diagnostic delay for pulmonary tuberculosis in Beijing. Int J Tuberc Lung Dis. 2014;18(3):267–71.
Li T, Zhang H, Shewade HD, Soe KT, Wang L, Du X. Patient and health system delays before registration among migrant patients with tuberculosis who were transferred out in China. BMC Health Serv Res. 2018;18(1):786.
International Diabetes Federation. IDF Diabetes Atlas 9th (2019). https://www.diabetesatlas.org. Accessed 17 May 2020.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5:e152.
Zheng C, Hu M, Gao F. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action. 2017;10(1):1–11.
Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus co-morbidity: a systematic review. PLoS One. 2017;12(4):e0175925.
Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lonnroth K, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis. 2015;19(8):879–86. https://doi.org/10.5588/ijtld.15.0069.
The International Union against Tuberculosis and Lung Disease. Management of diabetes mellitus- tuberculosis: a guide to the essential practice 2019. https://www.theunion.org/what-we- do/publications/technical/english/TheUnion_DMTB_Guide.pdf. Accessed 17 May 2020.
World Health Organization and the International Union against Tuberculosis and Lung Disease. Collaborative Framework for Care and Control of Tuberculosis and Diabetes 2011. https://www.theunion.org/what-we-do/publications/technical/english/collaborative framework tb-diabetes.pdf. Accessed 17 May 2020.
Li L, Lin Y, Mi F, Tan S, Liang B, Guo C, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Med Int Health. 2012;17(10):1294–301.
Wang Q, Ma A, Han X, Zhao S, Cai J, Ma Y, et al. Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study. PLoS One. 2013;8(12):e82660.
Zhong J, Yin J, Zou G, Hu Y, Walley J, Wang X, et al. Experience of implementing the integrated TB model in Zhejiang, China: a retrospective observational study. Trans R Soc Trop Med Hyg. 2016;110(4):246–51.
Wenzhou Prefectural Bureau of Statistics. 2018 Wenzhou Statistical Yearbook. http://wztjj.wenzhou.gov.cn/art/2018/11/14/art_1468704_24611681.html. Accessed 17 May 2020.
Zhejiang Provincial Bureau of Statistics. 2018 Zhejiang Statistical Yearbook. http://tjj.zj.gov.cn/col/col1525563/index.html. Accessed 17 May 2020.
TB Control Office in Ministry of Health in China. Implementation manual of the World Bank tuberculosis control program in China. 2nd ed. Beijing: Ministry of Health; 1992.
Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156.
Department of Disease Control, Department of Medical Administration, Chinese Center for Disease Control and Prevention. Guidelines for implementing the National Tuberculosis Control Program in China (version2008) (in Chinese).
Malbasa M, Pesut D. Is there delay in diagnosis of pulmonary tuberculosis in an intermediate-to-low TB incidence setting? Pneumologia. 2011;60(3):138–42.
Wang W, Jiang Q, Abdullah ASM, Xu B. Barriers in accessing to tuberculosis care among non- residents in Shanghai: a descriptive study of delays in diagnosis. Eur J Pub Health. 2007;17(5):419–23.
Abarca Tomás B, Pell C, Bueno Cavanillas A, Guillén Solvas J, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One. 2013;8(12):e82440.
Li X, Jiang S, Li X, Mei J, Zhong Q, Xu W, et al. Predictors on delay of initial health-seeking in new pulmonary tuberculosis cases among migrants population in East China. PLoS One. 2012;7(2):e31995.
Liang QF, Pang Y, Chen QY, Lin SF, Lin J, Zhao Y, et al. Genetic profile of tuberculosis among the migrant population in Fujian Province, China. Int J Tuberc Lung Dis. 2013;17(5):655–61.
Tobe RG, Xu L, Song P, Huang Y. The rural-to-urban migrant population in China: gloomy prospects for tuberculosis control. Biosci Trends. 2011;5(6):226–30.
Dang Y, Zou G, Peng B, Ling L. Health service seeking behavior among migrant Workers in Small and Medium-Sized Enterprises in Guangdong, China: does family migration matter? Biomed Res Int. 2018;2018:3620436.
Song X, Zou G, Chen W, Han S, Zou X, Ling L. Health service utilisation of rural-to-urban migrants in Guangzhou, China: does employment status matter? Tropical Med Int Health. 2017;22(1):82–91.
Zou G, Wei X, Deng S, Yin J, Ling L. Factors influencing the implementation of a pilot smoking cessation intervention among migrant workers in Chinese factories: a qualitative study. BMC Public Health. 2019;19(1):870.
Zou G, Zeng Z, Chen W, Ling L. Self-reported illnesses and service utilisation among migrants working in small-to medium sized enterprises in Guangdong, China. Public Health. 2015;129(7):970–8.
Wei X, Zou G, Yin J, Walley J, Yang H, Kliner M, et al. Providing financial incentives to rural-to- urban tuberculosis migrants in Shanghai: an intervention study. Infect Dis Poverty. 2012;1(1):9.
Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, et al. China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One. 2014;9(3):e90596. https://doi.org/10.1371/journal.pone.0090596.
Zou G, King R, Walley J, Yin J, Sun Q, Wei X. Barriers to hospital and tuberculosis programme collaboration in China: context matters. Glob Health Action. 2015;8(1):27067.
Martinez L, Xu L, Chen C, Sekandi JN, Zhu Y, Zhang C, et al. Delays and pathways to final tuberculosis diagnosis in patients from a referral Hospital in Urban China. Am J Trop Med Hyg. 2017;96(5):1060.